These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 31791065)

  • 1. Hepatitis C Virus Screening and Care: Complexity of Implementation in Primary Care Practices Serving Disadvantaged Populations.
    Turner BJ; Rochat A; Lill S; Bobadilla R; Hernandez L; Choi A; Guerrero JA
    Ann Intern Med; 2019 Dec; 171(12):865-874. PubMed ID: 31791065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hospital-Based Hepatitis C Screening of Baby Boomers in a Majority Hispanic South Texas Cohort: Successes and Barriers to Implementation.
    Taylor BS; Hanson JT; Veerapaneni P; Villarreal R; Fiebelkorn K; Turner BJ
    Public Health Rep; 2016; 131 Suppl 2(Suppl 2):74-83. PubMed ID: 27168665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustained virologic response from hepatitis C from an emergency department screening & linkage program: A retrospective review.
    Walter LA; Wilson L; Farmer M; Roberson T; Hand DT; Franco R
    Am J Emerg Med; 2023 Oct; 72():178-182. PubMed ID: 37540919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progress and challenges of a pioneering hepatitis C elimination program in the country of Georgia.
    Averhoff F; Shadaker S; Gamkrelidze A; Kuchuloria T; Gvinjilia L; Getia V; Sergeenko D; Butsashvili M; Tsertsvadze T; Sharvadze L; Zarkua J; Skaggs B; Nasrullah M
    J Hepatol; 2020 Apr; 72(4):680-687. PubMed ID: 31811882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Race and Hepatitis C Care Continuum in an Underserved Birth Cohort.
    Kim NJ; Locke CJ; Park H; Magee C; Bacchetti P; Khalili M
    J Gen Intern Med; 2019 Oct; 34(10):2005-2013. PubMed ID: 30238404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and Clinical Management of Persons with Chronic Hepatitis C Virus Infection - Cherokee Nation, 2012-2015.
    Mera J; Vellozzi C; Hariri S; Carabin H; Drevets DA; Miller A; Reilley B; Essex W; Gahn D; Lyons L; Leston J; Ward JW
    MMWR Morb Mortal Wkly Rep; 2016 May; 65(18):461-6. PubMed ID: 27172175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HCV core antigen as an alternative to HCV RNA testing in the era of direct-acting antivirals: retrospective screening and diagnostic cohort studies.
    van Tilborg M; Al Marzooqi SH; Wong WWL; Maan R; Vermehren J; Maasoumy B; Mazzulli T; Bolotin S; Garber G; Guerra F; Flud CR; Kowgier M; Janssen HL; de Knegt RJ; Pawlotsky JM; Cloherty GA; Duarte-Rojo A; Sarrazin C; Wedemeyer H; Feld JJ
    Lancet Gastroenterol Hepatol; 2018 Dec; 3(12):856-864. PubMed ID: 30274834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C Management at Federally Qualified Health Centers during the Opioid Epidemic: A Cost-Effectiveness Study.
    Assoumou SA; Nolen S; Hagan L; Wang J; Eftekhari Yazdi G; Thompson WW; Mayer KH; Puro J; Zhu L; Salomon JA; Linas BP
    Am J Med; 2020 Nov; 133(11):e641-e658. PubMed ID: 32603791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of direct-acting antiviral therapy for hepatitis C in difficult-to-treat patients in a safety-net health system: a retrospective cohort study.
    Yek C; de la Flor C; Marshall J; Zoellner C; Thompson G; Quirk L; Mayorga C; Turner BJ; Singal AG; Jain MK
    BMC Med; 2017 Nov; 15(1):204. PubMed ID: 29151365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High priority for hepatitis C screening in safety net hospitals: Results from a prospective cohort of 4582 hospitalized baby boomers.
    Turner BJ; Taylor BS; Hanson J; Liang Y; Veerapaneni P; Villarreal R; Perez M; Hernandez L; Sandhu J; Fiebelkorn K
    Hepatology; 2015 Nov; 62(5):1388-95. PubMed ID: 26250753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implementing hospital-based baby boomer hepatitis C virus screening and linkage to care: Strategies, results, and costs.
    Turner BJ; Taylor BS; Hanson JT; Perez ME; Hernandez L; Villarreal R; Veerapaneni P; Fiebelkorn K
    J Hosp Med; 2015 Aug; 10(8):510-6. PubMed ID: 26033458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacist-led drug therapy management for hepatitis C at a federally qualified health care center.
    Downes JM; Donovan A; McAdam-Marx C
    J Am Pharm Assoc (2003); 2022; 62(5):1596-1605. PubMed ID: 35595639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness and health-related outcomes of screening for hepatitis C in Korean population.
    Kim KA; Chung W; Choi HY; Ki M; Jang ES; Jeong SH
    Liver Int; 2019 Jan; 39(1):60-69. PubMed ID: 29998565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-Yield Birth-Cohort Hepatitis C Virus Screening and Linkage to Care Among Underserved African Americans, Atlanta, Georgia, 2012-2013.
    Miller LS; Rollin F; Fluker SA; Lundberg KL; Park B; Quairoli K; Niyibizi NK; Spaulding AC
    Public Health Rep; 2016; 131 Suppl 2(Suppl 2):84-90. PubMed ID: 27168666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementation of Universal Hepatitis C Virus Screening in a Tertiary Cancer Center.
    Torres HA; Mustafayev K; Juneau RP; Hwang JP; Wang LS; Angelidakis G; Hawk E; Granwehr BP; Yepez Guevara E; Ying AK
    J Natl Compr Canc Netw; 2024 May; 22(2D):. PubMed ID: 38729204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocellular carcinoma decreases the chance of successful hepatitis C virus therapy with direct-acting antivirals.
    Prenner SB; VanWagner LB; Flamm SL; Salem R; Lewandowski RJ; Kulik L
    J Hepatol; 2017 Jun; 66(6):1173-1181. PubMed ID: 28161470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Change in treatment paradigm in people who previously injected drugs with chronic hepatitis C in the era of direct-acting antiviral therapy.
    Wong GL; Chan HL; Loo CK; Hui YT; Fung JY; Cheung D; Chung C; Chim AM; Wong VW;
    J Gastroenterol Hepatol; 2019 Sep; 34(9):1641-1647. PubMed ID: 30707777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NIH Consensus Statement on Management of Hepatitis C: 2002.
    NIH Consens State Sci Statements; 2002 Jun 10-12; 19(3):1-46. PubMed ID: 14768714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HCV Testing and Treatment in a National Sample of US Federally Qualified Health Centers during the Opioid Epidemic.
    Assoumou SA; Wang J; Nolen S; Eftekhari Yazdi G; Mayer KH; Puro J; Salomon JA; Linas BP
    J Gen Intern Med; 2020 May; 35(5):1477-1483. PubMed ID: 32133577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained virologic response to direct-acting antiviral agents predicts better outcomes in hepatitis C virus-infected patients: A retrospective study.
    Colussi G; Donnini D; Brizzi RF; Maier S; Valenti L; Catena C; Cavarape A; Sechi LA; Soardo G
    World J Gastroenterol; 2019 Oct; 25(40):6094-6106. PubMed ID: 31686765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.